Elucidating acquired PARP inhibitor resistance in advanced prostate cancer.

Seed G, Beije N, Yuan W, Bertan C, Goodall J, Lundberg A, Tyler M, Figueiredo I, Pereira R, Baker C, Bogdan D, Gallagher L, Cieslik JP, Greening S, Lambros M, Neves R, Magraner-Pardo L, Fowler G, Ebbs B, Miranda S, Flohr P, Bianchini D, Rescigno P, Porta N, Hall E, Gurel B, Tunariu N, Sharp A, Pettit S, Stoecklein NH, Sandhu S, Quigley D, Lord CJ, Mateo J, Carreira S, de Bono J

Open source

DOI: 10.1016/j.ccell.2024.10.015
Published: 2024 Dec 9
Container: Cancer cell
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ccell.2024.10.015,
  title = {Elucidating acquired PARP inhibitor resistance in advanced prostate cancer.},
  author = {Seed G and Beije N and Yuan W and Bertan C and Goodall J and Lundberg A and Tyler M and Figueiredo I and Pereira R and Baker C and Bogdan D and Gallagher L and Cieslik JP and Greening S and Lambros M and Neves R and Magraner-Pardo L and Fowler G and Ebbs B and Miranda S and Flohr P and Bianchini D and Rescigno P and Porta N and Hall E and Gurel B and Tunariu N and Sharp A and Pettit S and Stoecklein NH and Sandhu S and Quigley D and Lord CJ and Mateo J and Carreira S and de Bono J},
  year = {2024},
  journal = {Cancer cell},
  doi = {10.1016/j.ccell.2024.10.015},
  url = {https://doi.org/10.1016/j.ccell.2024.10.015}
}

RIS

TY  - JOUR
TI  - Elucidating acquired PARP inhibitor resistance in advanced prostate cancer.
AU  - Seed G
AU  - Beije N
AU  - Yuan W
AU  - Bertan C
AU  - Goodall J
AU  - Lundberg A
AU  - Tyler M
AU  - Figueiredo I
AU  - Pereira R
AU  - Baker C
AU  - Bogdan D
AU  - Gallagher L
AU  - Cieslik JP
AU  - Greening S
AU  - Lambros M
AU  - Neves R
AU  - Magraner-Pardo L
AU  - Fowler G
AU  - Ebbs B
AU  - Miranda S
AU  - Flohr P
AU  - Bianchini D
AU  - Rescigno P
AU  - Porta N
AU  - Hall E
AU  - Gurel B
AU  - Tunariu N
AU  - Sharp A
AU  - Pettit S
AU  - Stoecklein NH
AU  - Sandhu S
AU  - Quigley D
AU  - Lord CJ
AU  - Mateo J
AU  - Carreira S
AU  - de Bono J
PY  - 2024
JO  - Cancer cell
DO  - 10.1016/j.ccell.2024.10.015
UR  - https://doi.org/10.1016/j.ccell.2024.10.015
ER  -

APA

G, S., N, B., W, Y., C, B., J, G., A, L., M, T., I, F., R, P., C, B., D, B., L, G., JP, C., S, G., M, L., R, N., L, M., G, F., B, E., S, M., P, F., D, B., P, R., N, P., E, H., B, G., N, T., A, S., S, P., NH, S., S, S., D, Q., CJ, L., J, M., S, C., & J, D. B. (2024). Elucidating acquired PARP inhibitor resistance in advanced prostate cancer.. Cancer cell. https://doi.org/10.1016/j.ccell.2024.10.015

Source records

pubmed · retrieved 2026-09-26T08:31:05.424Z